NF-κB gene signature predicts prostate cancer progression.
about
Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancerKnockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsLow vitamin D status is associated with inflammation in patients with prostate cancerA screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancerThe host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activationInferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factorRoles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive valueKPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients.TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.An Immune-Inflammation Gene Expression Signature in Prostate Tumors of SmokersTargeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1Synergistic action of image-guided radiotherapy and androgen deprivation therapy.Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-κB and HSP90 in castration resistant prostate cancer.Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to AntiandrogensMechanisms of Therapeutic Resistance in Prostate Cancer.Function of phosphorylation of NF-kB p65 ser536 in prostate cancer oncogenesis.SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.A possible role of GDDR in the development of Helicobacter pylori-associated gastric cancer.The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells.Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer.SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomasmiR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth.Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.Inhibition of KPNA4 attenuates prostate cancer metastasis.Functional evidence that progenitor cells near sites of inflammation are precursors for aggressive prostate cancer.NF-κB, the Importance of Being Dynamic: Role and Insights in Cancer.Role of the TNF-α receptor type 1 on prostate carcinogenesis in knockout mice.Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.Phyto-polyphenols as potential inhibitors of breast cancer metastasis.Identification of a gene-expression predictor for diagnosis and personalized stratification of lupus patients.Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation
P2860
Q30938412-6027628B-ED70-4723-A32D-E66247736D6DQ33563699-BAD46A9B-7ECD-4E6E-98D7-09FE03FF4197Q33591811-B14DD8EE-A56F-4D0A-ABD5-53D2A50559FCQ34483490-829D173B-3C32-4E27-A972-8F0266FF5091Q34699785-1FF9348C-CFDE-444D-8A84-72B3EFFAC9EFQ35099514-680916DC-DF2C-406A-BD65-DC8DC7786249Q35376685-DC36B6F1-F234-4657-851C-AD4F1DEA215DQ35380380-EF4D0488-CAE9-4C9D-9F9E-31EC2263EABEQ35503492-5CFAE912-AE2B-4427-8910-37BA4F447197Q35856215-28D17801-117B-424C-867C-BD03C300DB5DQ36043833-F809112F-4FC2-44A1-8A00-EC6D987F1316Q36232040-5A4F85D8-80D8-4321-A9A0-E3ECCC858B8EQ36642820-55CC2235-D441-46A3-867F-313F263FF205Q37075277-6210BC46-F2C1-4B51-BA6B-751D480CBF40Q37641718-1942FFBE-4370-46DD-8CFB-B95942E2E85AQ38261816-3D5BDA0E-DD06-4A6B-A2BE-6E584CDC77C5Q38387844-529BB36A-24DA-4EC9-ABA2-3DC7DD78A9B8Q38402398-E8A1A4EB-0859-435C-83CA-6C8EAF4C17B1Q38711529-3CE91AAD-E34B-4DB1-A9C1-B454EC1B2BA7Q38754316-D2730958-0162-4AE1-AD05-D8AE44305E85Q38902498-BF8BA2DC-8F02-472E-AF1F-92EBAC4B1E9AQ38924340-C9228AD6-DC88-4A0D-8CE4-AABEA1933088Q39438805-E4E1F6FB-C4C1-4ED8-BFEB-A70E48E95B8FQ40806324-E720ABED-1802-49A8-BC42-6CECEECBAE9BQ41134167-76F6BE79-101C-4E22-AD81-7130ADC8BEADQ41255874-113EA165-44EF-44A4-BC27-18F42F62B6F8Q41270542-1E44456C-B3CC-4AAE-98F8-54430E13D8B7Q42007974-44C40E3E-730C-476F-947D-82BAD161B9C5Q42259363-8551DB81-BDE0-492F-903B-98393DD95FC0Q44120498-56B63489-4529-465B-BFF6-5AF503C9F252Q46797418-2095B933-8A37-4F35-BAFC-919DE5D86E2EQ46906547-AAF11346-7B00-44D2-B411-2398338C3C92Q52315473-2B388D1B-7BA5-45BE-9657-3CE0496F74C2Q53204207-BE13153F-7F2A-4C62-A412-EA6691023FD4Q53372753-3817103C-A3A9-48D0-9C29-349C5E4A2A8BQ55208854-4F809A26-65FF-4DDC-A33A-28A9E4294780Q55491670-EF9A1BE9-14D8-4B5E-ADB7-657B2FA296B3Q55716933-5E08508E-ADCD-47B7-A7B3-181240E7C5F2Q58777826-DB90BE22-7D4F-4D2C-AD6B-538DF4D15A34
P2860
NF-κB gene signature predicts prostate cancer progression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NF-κB gene signature predicts prostate cancer progression.
@ast
NF-κB gene signature predicts prostate cancer progression.
@en
type
label
NF-κB gene signature predicts prostate cancer progression.
@ast
NF-κB gene signature predicts prostate cancer progression.
@en
prefLabel
NF-κB gene signature predicts prostate cancer progression.
@ast
NF-κB gene signature predicts prostate cancer progression.
@en
P2093
P2860
P1433
P1476
NF-κB gene signature predicts prostate cancer progression.
@en
P2093
Fiona E Yull
Joseph A Smith
Peter E Clark
Renjie Jin
Robert J Matusik
Tatsuki Koyama
Timothy S Blackwell
P2860
P304
P356
10.1158/0008-5472.CAN-13-2543
P407
P577
2014-03-31T00:00:00Z